372 related articles for article (PubMed ID: 18174284)
1. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.
De Sousa Peixoto RA; Turban S; Battle JH; Chapman KE; Seckl JR; Morton NM
Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284
[TBL] [Abstract][Full Text] [Related]
2. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
[TBL] [Abstract][Full Text] [Related]
3. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children.
Zhu L; Hou M; Sun B; Burén J; Zhang L; Yi J; Hernell O; Li X
J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225
[TBL] [Abstract][Full Text] [Related]
4. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue.
Veilleux A; Laberge PY; Morency J; Noël S; Luu-The V; Tchernof A
J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):28-34. PubMed ID: 20206259
[TBL] [Abstract][Full Text] [Related]
5. 11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol.
Bujalska IJ; Walker EA; Tomlinson JW; Hewison M; Stewart PM
Endocr Res; 2002 Nov; 28(4):449-61. PubMed ID: 12530648
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
7. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
Morton NM; Seckl JR
Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
[TBL] [Abstract][Full Text] [Related]
8. 7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type.
Wamil M; Andrew R; Chapman KE; Street J; Morton NM; Seckl JR
Endocrinology; 2008 Dec; 149(12):5909-18. PubMed ID: 18755798
[TBL] [Abstract][Full Text] [Related]
9. Ceramide and adenosine 5'-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes.
Arai N; Masuzaki H; Tanaka T; Ishii T; Yasue S; Kobayashi N; Tomita T; Noguchi M; Kusakabe T; Fujikura J; Ebihara K; Hirata M; Hosoda K; Hayashi T; Sawai H; Minokoshi Y; Nakao K
Endocrinology; 2007 Nov; 148(11):5268-77. PubMed ID: 17702848
[TBL] [Abstract][Full Text] [Related]
10. Role of 11-beta-hydroxysteroid dehydrogenase type 1 in differentiation of 3T3-L1 cells and in rats with diet-induced obesity.
Liu Y; Sun WL; Sun Y; Hu G; Ding GX
Acta Pharmacol Sin; 2006 May; 27(5):588-96. PubMed ID: 16626514
[TBL] [Abstract][Full Text] [Related]
11. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
Li X; Lindquist S; Chen R; Myrnäs T; Angsten G; Olsson T; Hernell O
Int J Obes (Lond); 2007 May; 31(5):820-8. PubMed ID: 17060929
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
[TBL] [Abstract][Full Text] [Related]
13. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children.
Wang J; Sun B; Hou M; Pan X; Li X
Int J Obes (Lond); 2013 Jul; 37(7):999-1005. PubMed ID: 23090578
[TBL] [Abstract][Full Text] [Related]
14. A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis.
Bujalska IJ; Gathercole LL; Tomlinson JW; Darimont C; Ermolieff J; Fanjul AN; Rejto PA; Stewart PM
J Endocrinol; 2008 May; 197(2):297-307. PubMed ID: 18434359
[TBL] [Abstract][Full Text] [Related]
15. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
Paulsen SK; Pedersen SB; Fisker S; Richelsen B
Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid reamplification within cells intensifies NF-kappaB and MAPK signaling and reinforces inflammation in activated preadipocytes.
Ishii-Yonemoto T; Masuzaki H; Yasue S; Okada S; Kozuka C; Tanaka T; Noguchi M; Tomita T; Fujikura J; Yamamoto Y; Ebihara K; Hosoda K; Nakao K
Am J Physiol Endocrinol Metab; 2010 May; 298(5):E930-40. PubMed ID: 19776225
[TBL] [Abstract][Full Text] [Related]
17. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
[TBL] [Abstract][Full Text] [Related]
18. The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
Tomlinson JW; Stewart PM
Horm Metab Res; 2002; 34(11-12):746-51. PubMed ID: 12660893
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of 11beta-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat.
Bujalska IJ; Durrani OM; Abbott J; Onyimba CU; Khosla P; Moosavi AH; Reuser TT; Stewart PM; Tomlinson JW; Walker EA; Rauz S
J Endocrinol; 2007 Feb; 192(2):279-88. PubMed ID: 17283228
[TBL] [Abstract][Full Text] [Related]
20. Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1.
Man TY; Michailidou Z; Gokcel A; Ramage L; Chapman KE; Kenyon CJ; Seckl JR; Morton NM
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1076-84. PubMed ID: 21406612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
